No Data
No Data
Truist Financial Maintains Catalyst Pharmaceuticals(CPRX.US) With Buy Rating
Catalyst Pharmaceuticals(CPRX.US) Officer Sells US$4.89 Million in Common Stock
Express News | Form 144 | Catalyst Pharmaceuticals(CPRX.US) Officer Proposes to Sell 3.9 Million in Common Stocks
Catalyst Pharmaceuticals' (NASDAQ:CPRX) Solid Earnings Are Supported By Other Strong Factors
Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
Catalyst Pharmaceuticals Is Maintained at Outperform by Baird